ALFA Finder| Metric | Q3 FY26 | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Other income | 13.2 | 24.3 | 13.2 |
| Total income | 206.0 | 190.0 | 332.0 |
| Net profit | 40.2 | 52.1 | 99.0 |
| Operating margin | 26.2% | 36.2% | 40.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -59.40% |
|---|---|
| Net profit, quarter on quarter | -22.80% |
BSE results filing, NSE: BLUEJET. Figures extracted from the filing.
Blue Jet Healthcare Ltd: key numbers
- Share price
- ₹539.35
- Market cap
- ₹9,356 Cr
- Revenue (annual)
- ₹947.3 Cr
- Net profit (annual)
- ₹247.8 Cr
- P/E (TTM)
- 32.8×Sector 43.7×
- Promoter holding
- 73.15%-6.66% QoQ
- FII holding
- 0.81%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Blue Jet Healthcare Ltd
All →Blue Jet Healthcare Partnership
Blue Jet Healthcare signed a non-binding MoU with Andhra Pradesh's APEDB. It is evaluating 50 acres for a Rs 500 Crore API manufacturing facility.
- Value
- ₹500.0 Cr
- Execution
- MoU valid for 12 months from the date of signing
Blue Jet Healthcare Earnings Call Transcript: Key Takeaways
Record Q2 FY27 revenue of about ₹376 Cr (+28% QoQ), but gross margin fell 4ppt to 49% on West Asia raw-material costs. Management gave no numerical forward guidance; margin recovery depends on price hikes from Q3.
Blue Jet Healthcare Other Announcement
Blue Jet Healthcare filed CARE Ratings' monitoring agency report for the QIP proceeds for the quarter ended 30 September 2026. The report shows nil deviation from the offer objects on the ₹800 crore issue.
Blue Jet Healthcare Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs3,757mn (record, +127% YoY), EBITDA Rs1,188mn (31.6%), PAT Rs1,025mn (27.3%). H1 FY27 revenue Rs6,689mn, PAT Rs1,808mn. Growth led by pharma intermediates and API.
Blue Jet Healthcare Q2 FY27 Results: Net Profit ₹102.5 Cr, Up 96.7% YoY
Blue Jet Healthcare reported standalone financial results for the quarter ended September 30, 2026. Revenue from operations reached Rs.375.74 Crore with a net profit of Rs.102.52 Crore.
- Key figure
- Net profit ₹102.5 Cr · +96.7% YoY
Blue Jet Healthcare Board Meeting Date
Blue Jet Healthcare scheduled a board meeting on November 5, 2026, to consider Q1 FY27 unaudited results. No financial figures are disclosed.